| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.08 | 0.2 |